Clinical Trial Update: IBD Disease Course of Infliximab-naïve IBD Patients Treated With Subcutaneous Infliximab CT-P13 Remsima® [NA]

View source ↗

Summary

Clinical trial update describing the disease course of infliximab-naïve inflammatory bowel disease patients treated with subcutaneous CT-P13 (Remsima) inflixima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Remsima (infliximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Inflammatory Bowel Diseases | NA | Status: ACTIVE_NOT_RECRUITING